Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hsueh-Yun Lee

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|October 9, 2018
Nitro-Group-Containing DrugsKunal Nepali, Hsueh-Yun Lee, Jing-Ping Liou
Journal of Natural Products|April 22, 2017
Total Synthesis of Two Glycosylated Stilbenes, Oxyresveratrol 2-O-β-d-Glucopyranoside and 2,3,5,4'-Tetrahydroxystilbene 2-O-β-d-GlucopyranosideSunil Kumar, Hsueh-Yun Lee, Jing-Ping Liou
Expert Opinion on Investigational Drugs|May 18, 2016
Early investigational tubulin inhibitors as novel cancer therapeuticsKunal Nepali, Ritu Ojha, Hsueh-Yun Lee, et al.
Journal of Natural Products|March 25, 2016
Total Synthesis of DenbinobinHsueh-Yun Lee, Sunil Kumar, Tzu-Cheng Lin, et al.
Chemico-Biological Interactions|December 20, 2021
A novel HDAC1/2 inhibitor suppresses colorectal cancer through apoptosis induction and cell cycle regulationHsueh-Yun Lee, Di-Wei Tang, Chi-Yuan Liu, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 25, 2021
Ring size changes in the development of class I HDAC inhibitorsEr-Chieh Cho, Chi-Yuan Liu, Di-Wei Tang, et al.
Expert Opinion on Therapeutic Patents|December 10, 2013
Tubulin inhibitors: a patent reviewYi-Min Liu, Hsiao-Ling Chen, Hsueh-Yun Lee, et al.
Bioorganic & Medicinal Chemistry|January 23, 2026
Targeting epithelial-mesenchymal transition and apoptosis: novel histone methyltransferase inhibitors for colon cancer suppressionHsueh-Yun Lee, Chia-Hsuan Chang, Yi-Ting Liu, et al.
European Journal of Medicinal Chemistry|October 18, 2021
Design, synthesis and biological evaluation of bisindole derivatives as anticancer agents against Tousled-like kinasesSung-Bau Lee, Ting-Yu Chang, Nian-Zhe Lee, et al.
Bioorganic & Medicinal Chemistry|June 19, 2024
Enhancing anti-cancer capacity: Novel class I/II HDAC inhibitors modulate EMT, cell cycle, and apoptosis pathwaysHsueh-Yun Lee, Min-Jung Hsu, Hao-Hsien Chang, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|October 9, 2018
Nitro-Group-Containing DrugsKunal Nepali, Hsueh-Yun Lee, Jing-Ping Liou
Journal of Natural Products|April 22, 2017
Total Synthesis of Two Glycosylated Stilbenes, Oxyresveratrol 2-O-β-d-Glucopyranoside and 2,3,5,4'-Tetrahydroxystilbene 2-O-β-d-GlucopyranosideSunil Kumar, Hsueh-Yun Lee, Jing-Ping Liou
Expert Opinion on Investigational Drugs|May 18, 2016
Early investigational tubulin inhibitors as novel cancer therapeuticsKunal Nepali, Ritu Ojha, Hsueh-Yun Lee, et al.
Journal of Natural Products|March 25, 2016
Total Synthesis of DenbinobinHsueh-Yun Lee, Sunil Kumar, Tzu-Cheng Lin, et al.
Chemico-Biological Interactions|December 20, 2021
A novel HDAC1/2 inhibitor suppresses colorectal cancer through apoptosis induction and cell cycle regulationHsueh-Yun Lee, Di-Wei Tang, Chi-Yuan Liu, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 25, 2021
Ring size changes in the development of class I HDAC inhibitorsEr-Chieh Cho, Chi-Yuan Liu, Di-Wei Tang, et al.
Expert Opinion on Therapeutic Patents|December 10, 2013
Tubulin inhibitors: a patent reviewYi-Min Liu, Hsiao-Ling Chen, Hsueh-Yun Lee, et al.
Bioorganic & Medicinal Chemistry|January 23, 2026
Targeting epithelial-mesenchymal transition and apoptosis: novel histone methyltransferase inhibitors for colon cancer suppressionHsueh-Yun Lee, Chia-Hsuan Chang, Yi-Ting Liu, et al.
European Journal of Medicinal Chemistry|October 18, 2021
Design, synthesis and biological evaluation of bisindole derivatives as anticancer agents against Tousled-like kinasesSung-Bau Lee, Ting-Yu Chang, Nian-Zhe Lee, et al.
Bioorganic & Medicinal Chemistry|June 19, 2024
Enhancing anti-cancer capacity: Novel class I/II HDAC inhibitors modulate EMT, cell cycle, and apoptosis pathwaysHsueh-Yun Lee, Min-Jung Hsu, Hao-Hsien Chang, et al.
Pageof 6